Everest Medicines Announces South Korea Grants Fast-Track Review Designation to Nefecon for Primary IgA Nephropathy Treatment
[vc_row css=".vc_custom_1673945307328{margin-top: -10px !important;}"][vc_column][vc_row_inner][vc_column_inner width="1/4"][vc_single_image image="9845" img_size="full" alignment="center" style="vc_b ...